-
Oct 1, 2026, 10:18 am84 pts
New York PostThe drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year.
Trending Today on Gossip Bucket
A big swirling bucket of the latest rumors, celebrity news and Hollywood gossip. The premier celebrity gossip app. The only apps that gives you a comprehensive real time celeb news stream.
Gossip Bucket aggregates and streams the latest gossip news and headlines from the top sources in one place.



















